Altamira Therapeutics Ltd. Shares Outstanding (Cover Page)
Altamira Therapeutics Ltd. (CYTOF) had Shares Outstanding (Cover Page) of 4.66 million shares as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2025-04-30
- 2024-12-31: Entity Common Stock, Shares Outstanding 4.66M shares.
- 2023-12-31: Entity Common Stock, Shares Outstanding 1.48M shares.
- 2022-12-31: Entity Common Stock, Shares Outstanding 1.18M shares.
- 2021-12-31: Entity Common Stock, Shares Outstanding 14.96M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2024-12-31 | 4.66M shares 20-F · filed 2025-04-30 |
| 2023-12-31 | 1.48M shares 20-F/A · filed 2024-07-01 |
| 2022-12-31 | 1.18M shares 20-F · filed 2023-05-16 |
| 2021-12-31 | 14.96M shares 20-F · filed 2022-04-12 |
| 2020-12-31 | 12.87M shares 20-F · filed 2021-03-31 |
| 2019-12-31 | 4.13M shares 20-F · filed 2020-04-16 |
| 2018-12-31 | 37.50M shares 20-F · filed 2019-03-14 |
| 2017-12-31 | 48.37M shares 20-F · filed 2018-03-22 |